Table 4 Multivariable analyses of factors associated with clinically significant weight loss and neonatal hyperbilirubinemia
Variable | Clinically significant weight loss N = 291 | Neonatal hyperbilirubinemia N = 287 | |||
|---|---|---|---|---|---|
Adjusted OR (95% CI) | p value | Adjusted OR (95% CI) | p value | ||
Ketamine dose (mg/kg)a | 0.77 (0.31–1.92) | 0.581 | 0.86 (0.38–1.94) | 0.719 | |
IV diazepam dose (mg/10 kg)a | 1.95 (1.13–3.34) | 0.016 | 1.87 (1.11–3.13) | 0.017 | |
PO diazepam | No | Reference group | – | Reference group | – |
Yes | 0.70 (0.24–1.98) | 0.497 | 1.11 (0.38–2.52) | 0.803 | |
Karen Ethnicity | No | – | – | Reference group | – |
Yes | – | – | 0.80 (0.37–1.72) | 0.561 | |
Pre-eclampsia | No | – | – | Reference group |  |
Yes | – | – | 0.72 (0.19–2.65) | 0.620 | |
Maternal obesity (BMI ≥ 27.5 kg/m2) | No | – | – | Reference group | – |
Yes | – | – | 3.71 (1.40–9.83) | 0.008 | |
Maternal Underweight (BMI < 18.5 kg/m2) | No | Reference group | – | – | – |
Yes | 3.97 (1.18–13.37) | 0.026 | – | – | |
Postpartum hemorrhage > 1 L | No | Reference group | – | – | – |
Yes | 4.38 (0.46–42.14) | 0.200 | – | – | |
5 Minute Apgar Score | 9 or 10 | Reference group | – | – | – |
≤8 | 6.53 (0.23–186.07) | 0.272 | – | – | |
Infant sex | Male | – | – | Reference group | – |
Female | – | – | 1.11 (0.51–2.44) | 0.782 | |
EGA at birth | ≥ 39 wks | Reference group | – | Reference group | – |
37- < 39 wks | 0.75 (0.23–2.43) | 0.634 | 2.15 (0.96–4.84) | 0.064 | |